0000000000111254

AUTHOR

Giulia Giandalia

showing 52 related works from this author

N-valproyl-L-tryptophan for CNS-targeting: synthesis, characterization and efficacy in vitro studies of a new potential antiepileptic drug.

2010

A new aminoacidic derivative of valproic acid (VPA) has been synthesized and characterized by analytical and spectral data. The rationale for the preparation of such potential antiepileptic agent is based on the observation that chemical combination of the anticonvulsant pharmacophore, VPA with essential aminoacids could afford more effective and less toxic actives. The synthesis, characterization, physico-chemical parameters functional for crossing Blood Brain Barrier of N-valproyl-L-tryptophan (4) are reported. The Log D pH7.4 (0.3) indicates that (4) is adequate to cross biological membranes. Its chemical and enzymatic stability were assessed. The experiments indicate high stability of c…

Malemedicine.medical_treatmentHippocampal formationPharmacologyIn Vitro TechniquesBlood–brain barrierSettore BIO/09 - FisiologiaHippocampuschemistry.chemical_compoundDrug StabilityIn vivoDrug DiscoverymedicineAnimalsRats WistarValproic AcidEpilepsyDipeptidesAminoacidic derivative Antiepileptic Drug CNS-Targeting Enzymatic Stability Seizure Like Events Model Valproic acidIn vitroElectrophysiological PhenomenaRatsmedicine.anatomical_structureAnticonvulsantchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoAnticonvulsantsPharmacophoreDerivative (chemistry)medicine.drugMedicinal chemistry (Shariqah (United Arab Emirates))
researchProduct

A three-cell type in vitro-model of BBB

2005

BBB in vitro model brain cells
researchProduct

Potential dopamine prodrug-loaded liposomes: preparation, characterization and in vitro stability studies

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoLiposomes Dopamine pro-drugs
researchProduct

Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features

2006

Abstract In transbuccal absorption a major limitation could be the low permeability of the mucosa which implies low drug bioavailability. The ability of naltrexone hydrochloride (NLX) to penetrate a resembling histologically human buccal mucosa was assessed and the occurrence of any histomorphological changes observed. We used reconstituted human oral (RHO) non-keratinised epithelium as mucosal section and a Transwell diffusion cells system as bicompartmental model. Buccal permeation was expressed in terms of drug flux ( J s ) and permeability coefficients ( K p ). Data were collected using both artificial and natural human saliva. The main finding was that RHO does not restrain NLX permeat…

Naltrexone HydrochlorideSalivaTissue FixationCell SurvivalNarcotic AntagonistsPharmaceutical SciencePharmacologySettore MED/08 - Anatomia PatologicaEpitheliumPermeabilityAbsorptionDiffusionExcipientsSettore MED/28 - Malattie OdontostomatologichemedicineHumansNaltrexone hydrochlorideNLXIontophoresiBuccal permeationTransbuccal absorptionParaffin EmbeddingIontophoresisChemistryNarcotic antagonistMouth MucosaAdministration BuccalGeneral MedicineBuccal administrationIontophoresisPermeationReconstituted human oral epithelium (RHO)Electric StimulationNaltrexoneEpitheliummedicine.anatomical_structurePenetration enhancersSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoData Interpretation StatisticalBiophysicsBiotechnology
researchProduct

ChemInform Abstract: Synthesis and in vitro Studies on a Potential Dopamine Prodrug.

2009

Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of blood-brain barrier (BBB) which is a selective interface that excludes most water-soluble molecules from entering the brain. Neutral amino acids permeate the BBB by specific transport systems. Condensation of dopamine with neutral amino acids could afford potential prodrugs able to interact with the BBB endogenous transporters and easily enter the brain. The synthesis and characterization of the dopamine derivative 2-amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (7) is described. The chemical and enzymatic stability of 7 was evaluated. The molecular weight (300 Da) and Log Papp (…

ChemistryEndogenyTransporterBiological membraneGeneral MedicineProdrugPharmacologyIn vitroMembraneIn vivoDopaminemedicineBiophysicsmedicine.drugChemInform
researchProduct

Trehalose-hydroxyethylcellulose microspheres containing vancomycin for topical drug delivery.

2001

Abstract A new formulation, in which vancomycin is entrapped into trehalose and hydroxyethylcellulose (Natrosol ® ) spherical matrices, is described. Microspheres were produced by the solvent evaporation method. The entrapped drug was fully recovered following microspheres dissolution. Differential scanning calorimetry analyses proved that Natrosol maintains trehalose in its amorphous form. The stabilizing effects of trehalose on vancomycin were evaluated even after long storage and heating of microspheres. Calorimetric data indicated no decomposition of the entrapped drug. In vitro drug release, already performed by using a general two-compartment linear time-invariant open model, suggests…

Active ingredientChromatographyChemistryStereochemistryPharmaceutical ScienceTrehaloseGeneral MedicineTrehaloseDosage formMicrospheresAnti-Bacterial Agentschemistry.chemical_compoundDifferential scanning calorimetryDrug Delivery SystemsSolubilityVancomycinLiberationDrug carrierCelluloseDissolutionBiotechnologyAntibacterial agentEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Formulazione di sistemi innovativi per la somministrazione di antitumorali per il trattamento del Carcinoma Orale Squamoso

2008

Carcinoma Orale SquamosoAntitumorali
researchProduct

Tablets for buccal administration of carbamazepine: comparative behavior of PAA microspheres and matrices

2005

researchProduct

Evaluation of Galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: Part I

2008

Over the last decade, interest in delivering drugs through buccal mucosa has increased. As a major limitation in buccal drug delivery could be the low permeability of the epithelium, the aim of this study was to evaluate the aptitude of galantamine, useful in Alzheimer's disease, to penetrate the buccal mucosa. The evaluation of the ability of galantamine to permeate through the buccal epithelium was investigated using two permeation models. Firstly, in vitro permeation experiments were carried out using reconstituted human oral non-keratinised epithelium and Transwell diffusion cells system. Results were validated by ex vivo experiments using porcine buccal mucosa as membrane and Franz typ…

Pathologymedicine.medical_specialtySwinePharmaceutical ScienceAbsorption (skin)BiologyPermeabilityDiffusionstomatognathic systemPharmacokineticsSettore MED/28 - Malattie OdontostomatologichemedicineAnimalsHumansTransbuccal permeationCells CulturedGalantamineMouth MucosaAdministration BuccalEpithelial CellsGeneral MedicineBuccal administrationPermeationIn vitroEpitheliumstomatognathic diseasesKineticsmedicine.anatomical_structureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryReconstituted human oral epithelium (HOE)Diffusion Chambers CultureCholinesterase InhibitorsPorcine buccal mucosaAlzheimer’s diseaseEx vivoBiotechnology
researchProduct

CNS-targeted valproic-aminoacid conjugate: preliminary studies on pharmacokinetic parameters and antiepileptic activity

2009

Brain delivery Prodrugs Physico-chemical caracteristics
researchProduct

Formulation and kinetic studies on matrix tablets loaded with 5-Fluorouracil useful in oral cancer treatment

2007

researchProduct

Sintesi, caratterizzazione e studio della stabilità chimica ed enzimatica di nuovi profarmaci della dopamina

2004

researchProduct

New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa

2012

The aptitude of ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson's disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using limonene or by application of electric fields. Absorption improvement was accompanied by the …

Absorption (pharmacology)IndolesTime FactorsSwinePharmaceutical SciencePharmacologyModels BiologicalPermeabilityAntiparkinson AgentsBuccal delivery Ropinirole Parkinson's disease Absorption enhancement Porcine buccal mucosaDrug Delivery SystemsElectricityCyclohexenesmedicineAnimalsAdjuvants PharmaceuticIontophoresisTerpenesChemistryMouth MucosaAdministration BuccalParkinson DiseasePenetration (firestop)Buccal administrationIontophoresisPermeationRopiniroleMembraneSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFeasibility StudiesLimoneneEx vivomedicine.drugBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Matrix system development, permeation studies and histological features for transbuccal delivery of Naltrexone

2007

researchProduct

Aminoacidic derivatives as novel CNS-targeted neurotherapeutics

2012

Drug delivery to the CNS is subject to the permeability limitations imposed by the BBB that regulates movements of actives in and out of the brain. During the drug discovery phase a key aspect could be the selection of the compounds properties crucial for brain penetration. Novel CNS-targeted neurotherapeutics should possess the optimal characteristics that allow passive diffusion through the BBB via the transcellular route, or have the structural features necessary to serve as a substrate for one of the endogenous transport systems of the BBB. An attractive and rewarding chemistry-based strategy, employed to increase the CNS transport of poorly penetrating therapeutic agents, is the transi…

CNS prodrugsSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Buccal Delivery of Carbamazepine (CBZ): a New Scenario in Menagement of Trigeminal Neuralgia (TN)

2008

Carbamazepinebuccal mucosa
researchProduct

Trehalose-loaded liposomes to regulate skin moisturization

2010

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoTrehalose Liposomes Moisturizing agents
researchProduct

Buccal delivery of Methimazole as an alternative means to optimize drug bioavailability: permeation studies and matrix system design

2012

The aim of this study was to investigate the potential for systemic administration of Methimazole (MMI) through the buccal mucosa as an alternative route for drug delivery. Considering that the most important restriction in buccal drug delivery could be the low permeability of the mucosa, the ability of MMI to cross the mucosal barrier was assessed. Permeation of MMI through porcine buccal mucosa was investigated ex vivo using Franz type diffusion cells, buffer solution simulating saliva or natural human saliva as donor phase. The collected data suggested that buccal mucosa does not hinder MMI diffusion and the drug crosses the membrane (Js = 0.068 mg cm-2 h-1 and Kp = 0.065 cm h-1). Matrix…

MethimazoleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPorcine buccal mucosaBuccal tabletsTransbuccal permeationHyperthyroidismEudragit® RS 100
researchProduct

Transbuccal delivery of methimazole: ex vivo permeation studies, histomorphological features and matrix system development

2008

MethimazoleBuccal mucosa
researchProduct

Potential dopamine prodrug-loaded liposomes: preparation, characterization, andin vitrostability studies

2010

Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of the blood-brain barrier (BBB). Condensation of dopamine with neutral amino acids could afford potential pro- drugs able to interact with the BBB endogenous transporters and easily enter the brain. To improve the bio-availability of the dopamine prodrug, 2-amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (DOPH), it was encapsulated in unilamellar liposomes of dimiristoylphosphatidylcholine (DMPC)and cholesterol. Vesicles were characterized by dynamic light scattering in order to evaluate their dimensions and vesicle stability, by zeta-potential measurements, by means of electronic mi…

LightDopaminePhenylalanineenzymatic stabilityPharmaceutical Sciencechemical stability; dopamine prodrug; enzymatic stability; liposomeschemical stabilityDrug StabilityDynamic light scatteringDopamineZeta potentialmedicineHumansScattering RadiationProdrugsLiposomeChromatographyCalorimetry Differential ScanningChemistryVesicleProdrugSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPermeability (electromagnetism)LiposomesliposomeBiophysicsChemical stabilityDimyristoylphosphatidylcholineDopamine prodrugmedicine.drugJournal of Liposome Research
researchProduct

5-Fluororacile-loaded matrix tablets for locoregional delivery: effects on a three-dimensional culture model of primary oral squamous cell carcinoma

2012

5-Fluorouracil Locoregional drug delivery Oral squamous cell carcinoma Buccal tablets 3D oral outgrowths
researchProduct

5-Fluorouracil Buccal Tablets for Locoregional Chemotherapy of Oral Squamous Cell Carcinoma: Formulation, Drug Release and Histological Effects on Re…

2010

5-Fluorouracil (5-FU) is currently used for treatment of oral squamous cell carcinoma (OSCC). 5-FU is given by i.v. although the systemic administration is associated with severe toxic effects and no topical formulations of 5-FU for buccal drug delivery have been reported. In this study we would report the development of buccal tablets suitable for direct application of low-doses of 5-FU on cancer lesions. The topical administration could be effective on tumor area while systemic undesired side effects are avoided. Preliminarily, the limited tendency of 5-FU to cross the buccal tissue was established using reconstituted human oral epithelium (RHOE, in vitro) and porcine buccal mucosa (ex vi…

DrugAntimetabolites AntineoplasticPathologymedicine.medical_specialtySwineChemistry PharmaceuticalDrug Compounding5-Fluorouracilmedia_common.quotation_subjectPharmaceutical ScienceApoptosisSettore MED/08 - Anatomia PatologicaLocoregional drug deliveryOral Squamous Cell CarcinomaPermeabilityTissue Culture TechniquesDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheCarcinomaAnimalsHumansMedicinemedia_commonbusiness.industryMouth MucosaAdministration BuccalCancerBuccal administrationmedicine.diseaseReconstituted Human Oral Epitheliumstomatognathic diseasesSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFluorouracilDrug deliveryCarcinoma Squamous CellSystemic administrationMouth NeoplasmsFluorouracilPorcine buccal mucosaBuccal tabletsbusinessEx vivoTabletsmedicine.drugCurrent Drug Delivery
researchProduct

Buccal delivery as a new challenge for treatment of motor fluctuations in Parkinson's Disease

2011

RopiniroleParkinson's DiseaseApomorphineSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBuccal deliveryL-Dopa methyl ester
researchProduct

Aloin loaded matrix tablets for topical treatment of oral cancer

2008

Aloinoral cancer
researchProduct

A NEW DOPAMINE-AMINOACID CONJUGATE: SYNTHESIS AND DETERMINATION OF PHYSICO-CHEMICAL PROPERTIES USEFUL TO CROSS THE BBB

2012

Aminoacidic prodrugs dopamine PAMPA-BBB Caco-2 modelSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

DOPAMINE PRO-DRUGS FOR CNS TARGETING: SYNTHESIS, CHARACTERIZATION AND HYDROLYSIS BY BRAIN ENZYMES.

2004

CNSbrain enzymesdopamine pro-drugs
researchProduct

Buccal Delivery of Methimazole as an Alternative Means for Improvement of Drug Bioavailability: Permeation Studies and Matrix System Design

2012

The aim of this study was to investigate the potential for systemic administration of Methimazole (MMI) through the buccal mucosa as an alternative route for drug delivery. Considering that the most important restriction in buccal drug delivery could be the low permeability of the mucosa, the ability of MMI to cross the mucosal barrier was assessed. Permeation of MMI through porcine buccal mucosa was investigated ex vivo using Franz type diffusion cells, buffer solution simulating saliva or natural human saliva as donor phase. The collected data suggested that buccal mucosa does not hinder MMI diffusion and the drug crosses the membrane (J(s) = 0.068 mg cm(-2) h(-1) and K(p) = 0.065 cm h(-1…

MaleDrugSwinemedia_common.quotation_subjectAcrylic ResinsBiological AvailabilityPharmacologyPermeabilityDosage formDiffusionExcipientsDrug Delivery SystemsAntithyroid Agentsstomatognathic systemDrug DiscoveryAnimalsHumansSalivamedia_commonPharmacologyMethimazoleChromatographyChemistryMouth MucosaAdministration BuccalBuccal administrationPermeationBioavailabilitySolubilityDrug deliverySystemic administrationEx vivoTabletsCurrent Pharmaceutical Design
researchProduct

Molecole aminoacidiche quali carriers di farmaci attivi sul sistema nervoso centrale

2004

researchProduct

Neurons and ECM regulate occludin localization in brain endothelial cells

2000

We report that extracellular matrix and neurons modulate the expression of occludin, one of the main components of tight junctions, by rat brain endothelial cells (RBE4.B). Of the three extracellular matrix proteins which we tested (collagen I, collagen IV, and laminin), collagen IV stimulated at the best the expression of occludin mRNA. The corresponding protein, however, was not synthesized. Significant amounts of occludin accumulated only when RBE4.B cells were cultured on collagen IV-coated inserts, in the presence of cortical neurons, plated on laminin-coated companion wells. Finally, occludin segregated at the cell periphery, only when endothelial cells were co- cultured with neurons …

Time FactorsEndothelial cellsCellOccludinTight JunctionsExtracellular matrixRats Sprague-DawleyFetusLamininNeurofilament ProteinsOccludinSettore BIO/10 - BiochimicaGlial Fibrillary Acidic ProteinmedicineAnimalsRNA MessengerCells CulturedBlood-brain barrierNeuronsbiologyTight junctionGeneral NeuroscienceBrainMembrane ProteinsCortical NeuronsExtracellular matrixImmunohistochemistryCell biologyRatsEndothelial stem cellmedicine.anatomical_structureMembrane proteinCell cultureSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCerebrovascular Circulationbiology.proteinSettore MED/26 - NeurologiaCollagenEndothelium VascularLamininNeuroscience
researchProduct

Trehalose/hydroxyethylcellulose ocular gelling microspheres.

2008

trehalose microspheres norfloxacin reconstituted human corneal epithelium
researchProduct

Transmucosal permeability model of 5-fluorouracil through porcine and reconstituted oral epithelium

2005

researchProduct

Effects of gamma-irradiation on trehalose–hydroxyethylcellulose microspheres loaded with vancomycin

2003

Ionizing radiation can be used as a drug sterilization technique, provided that the drug itself is not modified and that no toxic products are produced; moreover, if the irradiated product is a drug delivery system, the drug release characteristics must not be significantly altered by radiation. The aim of this work was to study the effects of sterilization by ionizing radiation on hydroxyethylcellulose/trehalose spherical micromatrices, containing the antibiotic vancomycin. Our experimental results showed that gamma-rays did not alter the chromophore groups of vancomycin (UV measurements), and did not modify the kinetic behavior of drug release from microspheres. Moreover, no significant c…

Ionizing radiationMicrosphereDrugmedia_common.quotation_subjectDrug delivery systemGamma-irradiationPharmaceutical Sciencelaw.inventionIonizing radiationchemistry.chemical_compoundVancomycinlawmedicineIrradiationCelluloseElectron paramagnetic resonanceESRmedia_commonRadiochemistryTrehaloseQuality controlGeneral MedicineSterilization (microbiology)Drug sterilizationTrehaloseMicrosphereschemistryGamma RaysDrug deliveryVancomycinBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Progettazione e realizzazione di sistemi di rilascio programmato nella terapia delle ferite da ustione

2004

researchProduct

Loaded sulfamethoxazole/trimethoprim soft films for treatment of burn wounds.

2006

researchProduct

Buccal delivery in treatment of Alzheimer disease: enhancement of galantamine absorption

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoBuccal Delivery Alzheimer diisease Galantamine
researchProduct

AMINOACID PRO-DRUG TO SHUTTLE VALPROIC ACID INTO CNS

2007

valproic acidaminoacid pro-drugCNS
researchProduct

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in…

2004

Summary Background  Topical application of clobetasol-17-propionate has been diffusely reported as an efficacious therapy in atrophic/erosive oral lichen planus (OLP), without exposing the patient to systemic side-effects. However, prolonged contact and respective topical effects on the oral mucosa should be avoided. Objectives  The aim of the present study was to evaluate efficacy and compliance of new lipid microspheres loaded with 0·025% of clobetasol propionate (formulation A) compared with a commonly used formulation (a sort of dispersion of a lipophilic ointment in a hydrophilic phase) with the same amount of drug (formulation B) in the topical treatment of OLP. Patients and methods  …

AdultMalemedicine.medical_specialtyRandomizationVisual analogue scaleAdministration TopicalChemistry PharmaceuticalAnti-Inflammatory AgentsDermatologyDosage formlaw.inventionOintmentsDrug Delivery SystemsRandomized controlled triallawMedicineHumansSingle-Blind MethodOral mucosaGlucocorticoidsAgedAged 80 and overClobetasolbusiness.industryMiddle Agedmedicine.diseaseDermatologyLipidsMicrospheresRegimenmedicine.anatomical_structureclobetasol propionate delivery lipid microspheres oral lichen planusPatient ComplianceOral lichen planusFemaleClobetasol propionatebusinessmedicine.drugLichen Planus OralThe British journal of dermatology
researchProduct

Evaluation of the aptitude to cross the BBB of a new dopamine aminoacidic prodrug

2012

One of the most important factors limiting the development of new drugs for the CNS is the ability to cross the BBB which is a barrier that controls the entrance and exit of both endogenous and exogenous compounds. BBB expresses several transport systems that carry actively into the brain important nutrients (e.g. glucose and amino acids) and are able to import or export various xenobiotics including drugs and their metabolites. The content of active in the brain depends on the overall difference between the drug uptake and drug efflux processes [1]. Dopamine (DA) is a crucial neurotransmitter; its striatal depletion is responsible of clinical signs of Parkinson’s disease (PD). Owing to the…

Parkinson diseasePAMPASettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBlood Brain BarrierDopamine prodrug
researchProduct

Ocular gelling microspheres: in vitro precorneal retention time and drug permeation through reconstituted corneal epithelium.

2008

Purpose: The model drug norfloxacin (NOR)was encapsulated into trehalose (TRH) and hydroxyethylcellulose(NAT) microspheres to obtain a novel gelling ophthalmic delivery system for prolonged release on corneal tissue. Methods: We assessed NOR release from microspheres, prepared by the emulsion-solvent evaporation method. A new in vitro tear turnover model, including inserts containing reconstituted human corneal epithelium (RHC), was designed to evaluate the TRH/NAT microspheres’ precorneal retention time. Bioadhesive properties of TRH/NAT microspheres were validated by using drug-loaded microspheres prepared with gelatine (GLT) commonly used as reference material in adhesion studies. Result…

endocrine systemmedicine.medical_specialtyBioadhesiveBiological AvailabilityReconstituted corneal epitheliumIn Vitro TechniquesDOSAGE FORMSPermeabilityDelayed-Action PreparationsAqueous Humorchemistry.chemical_compoundCorneamedicineHumansPharmacology (medical)CONTAINING LIPOSOMESCelluloseOcular microsphereCorneal epitheliumCell Line TransformedPharmacologyChromatographyEpithelium CornealAdhesivenessTrehaloseDELIVERY SYSTEMTrehaloseIn vitroMicrospheresSurgeryAnti-Bacterial AgentsTREHALOSE-HYDROXYETHYLCELLULOSE MICROSPHERESOphthalmologymedicine.anatomical_structurechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPermeability (electromagnetism)SOLUTE RELEASEDelayed-Action PreparationsGelatinSwellingmedicine.symptomOphthalmic SolutionsGelsNorfloxacinJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
researchProduct

Inclusion of Trehalose (TRH) into liposomes to regulate uptake of this cryoprotectant into human hepatocytes.

2009

Purpose. Problems with the limited availability of human hepatocytes for cell transplantation may be overcome by improving the efficiency of their cryopreservation. TRH-loaded liposomes could enhance epatocyte viability by regulating the intracellular uptake of the cryoprotectant [1]. Methods. TRH-loaded liposomes were prepared by film hydration method (EPC, sodium cholate, 200mM TRH solution) [2]. Liposomal size was determined by dynamic light scattering. Intraliposomal TRH content was measured using the Megazyme spectrophotometric method. After incubation (1-5 h, 37°C, 5% CO2, 95% RH) of human hepatocytes with TRH-loaded liposomes or equivalent TRH solution, intracellular sugar content wa…

LiposomeNanoscienceSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCell cultures
researchProduct

Sintesi di un nuovo derivato dell’acido valproico ed effetti in un modello sperimentale di epilessia ippocampale nel ratto

2008

acido valproico epilessia
researchProduct

Trehalose stabilizing effects on L-DOPA aqueous solutions

2007

researchProduct

Ex vivo transbuccal delivery of carbamazepine across porcine mucosa

2006

researchProduct

Enteric Aloin loaded microparticles for treatment of colorectal cancer

2008

Aloin Colorectal cancer
researchProduct

Galantamine permeation through buccal mucosa: studies on reconstituted human oral epithelium and porcine tissue

2008

HOEGalantaminePorcine buccal mucosaTransbuccal permeation
researchProduct

Functional feature of a novel model of blood brain barrier: Studies on permeation of test compounds

2001

Drug delivery to the central nervous system (CNS) is subject to the permeability limitations imposed by the blood-brain barrier (BBB). Several systems in vitro have been described to reproduce the physical and biochemical behavior of intact BBB, most of which lack the feature of the in vivo barrier. We developed a fully formed monolayer of RBE4.B immortalized rat brain microvessel endothelial cells (ECs), grown on top of polycarbonate filter inserts with cortical neuronal cells grown on the outside. Neurons induce ECs to synthesize and sort occludin to the cell periphery. Occludin localization is regulated by both compositions of the substratum and soluble signals released by cortical co-cu…

DopamineL-DOPAPharmaceutical ScienceBrain capillaries endothelial cells (ECs)OccludinBlood–brain barrierDopamine agonistPermeabilityLevodopaRats Sprague-DawleyDopamineIn vivoSettore BIO/10 - BiochimicamedicineAnimalsCells CulturedChemistryTryptophanPermeationRatsEndothelial stem cellBlood-brain barrier (BBB)medicine.anatomical_structureBiochemistryPermeability (electromagnetism)Blood-Brain BarrierSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsSettore MED/26 - Neurologiamedicine.drugL-Tryptophan
researchProduct

Release of naltrexone on buccal mucosa: Permeation studies, histological aspects and matrix system design

2007

Transbuccal drug delivery has got several well-known advantages especially with respect to peroral way. Since a major limitation in buccal drug delivery could be the low permeability of the epithelium, the aptitude of NLX to penetrate the mucosal barrier was assessed. Ex vivo permeation across porcine buccal mucosa 800 microm thick was investigated using Franz type diffusion cells and compared with in vitro data previously obtained by reconstituted human oral epithelium 100 microm thick. Both fluxes (Js) and permeability coefficients (K(p)) are in accordance, using either buffer solution simulating saliva or natural human saliva. Permeation was evaluated also in presence of chemical enhance…

Naltrexone HydrochlorideTime FactorsSpectrophotometry InfraredSwineChemistry PharmaceuticalNarcotic AntagonistsPharmaceutical SciencePharmacologyDosage formDrug Delivery SystemsFormaldehydeAnimalspermeation studieNLXIontophoresisChemistryNarcotic antagonistDrug Administration RoutesMouth MucosaAdministration Buccalsystem design.General MedicineBuccal administrationIontophoresisPermeationmatrixKineticsbuccal mucoDrug deliveryhistological aspectnaltrexoneTabletsBiotechnologyEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Synthesis and in vitro studies on a potential dopamine prodrug.

2008

Dopamine delivery to the central nervous system (CNS) undergoes the permeability limitations of blood-brain barrier (BBB) which is a selective interface that excludes most water-soluble molecules from entering the brain. Neutral amino acids permeate the BBB by specific transport systems. Conden- sation of dopamine with neutral amino acids could afford potential prodrugs able to interact with the BBB endogenous transporters and easily enter the brain. The synthesis and characterization of the dopamine derivative 2-amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (7) is de- scribed. The chemical and enzymatic stability of 7 was evaluated. The molecular weight (300 Da) and Log P …

Magnetic Resonance SpectroscopyChemistry PhysicalDopamineenzymatic stabilityMembranes ArtificialBuffersSettore CHIM/08 - Chimica FarmaceuticaRatschemical stabilityRats Sprague-DawleyDrug Delivery SystemsSolubilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDopamine ProdrugAnimalsHumansIndicators and ReagentsProdrugsIntestinal MucosaDie Pharmazie
researchProduct

Medium-Term Culture of Primary Oral Squamous Cell Carcinoma in a Three- Dimensional Model: Effects on Cell Survival Following Topical 5-Fluororacile …

2012

Since the activity of several conventional anticancer drugs is restricted by resistance mechanisms and dose-limiting side-effects, the design of formulations for local application on malignant lesions seems to be an efficient and promising drug delivery approach. In this study, the effect of locally applied 5-FU on cell death was evaluated both in a SCC4/HEK001 model and in a newly proposed 3D outgrowth model of oral squamous cell carcinoma (OSCC). Initially, the optimal drug dose was established by delivery of solutions containing different amounts of 5-FU. The solution containing 1% (w/v) of 5-FU resulted effective in inducing cell death with complete eradication of cell colonies. Buccal …

DrugAntimetabolites AntineoplasticProgrammed cell deathCell Survivalmedia_common.quotation_subjectCellCell Culture TechniquesApoptosisCell CommunicationMatrix (biology)PharmacologyExcipientsDrug Delivery SystemsMicroscopy Electron TransmissionCell Line TumorDrug DiscoverymedicineHumansmedia_commonPharmacologyTUNEL assayDose-Response Relationship Drugbusiness.industryCancerBuccal administrationmedicine.diseasemedicine.anatomical_structureAcrylatesDrug deliveryCarcinoma Squamous CellMethacrylatesMouth NeoplasmsFluorouracilbusinessTabletsCurrent Pharmaceutical Design
researchProduct

Inhibitory effects of N-valproyl-L-tryptophan on high potassium, low calcium and low magnesium-induced CA1 hippocampal epileptiform bursting activity…

2012

N-valproyl-l-tryptophan (VPA-Tryp), new antiepileptic drug, was tested on CA1 hippocampal epileptiform bursting activity obtained by increasing potassium and lowering calcium and magnesium concentrations in the fluid perfusing rat brain slices. Each slice was treated with a single concentration (0.2, 0.5, 1 or 2 mM) of Valproate (VPA) or VPA-Tryp. Both burst duration and interburst frequency during and after treatment were off-line compared with baseline values. For both parameters, the latency and the length of statistically significant response periods as well as the magnitude of drug-induced responses were calculated. VPA-Tryp evoked fewer and weaker early excitatory effects than VPA on …

Maleantiepileptic drug valproic acidPotassiumchemistry.chemical_elementAction PotentialsCalciumHippocampal formationPharmacologyIn Vitro TechniquesInhibitory postsynaptic potentialSettore BIO/09 - Fisiologiaamino-acidic derivativeBurstingmedicineReaction Timehippocampal epilepsyAnimalsDrug InteractionsMagnesiumRats WistarCA1 Region HippocampalBiological PsychiatryValproic AcidAnalysis of VarianceDose-Response Relationship DrugMagnesiumDipeptidesElectric StimulationRatsPsychiatry and Mental healthNeurologychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoExcitatory postsynaptic potentialPotassiuminterictal burstslipids (amino acids peptides and proteins)AnticonvulsantsNeurology (clinical)medicine.drugJournal of neural transmission (Vienna, Austria : 1996)
researchProduct

Optimization of local delivery of antifungal agents in the oral cavity by a new formulation

2012

In recent years, with the increased use of antibiotics and immunosuppres-sive agents, there was an increased incidence of oral mycosis and Candida albicans is the most common etiologic agent in oropharyngeal candidiasis, especially in patients with HIV. The aim of this work is to develop a new dosage form containing miconazole (MN) to be topically applied on oral mucosa, allowing for a massive penetration of the drug in the tissue. The vehicle for the drug delivery was lipid microparticles incorporated in a hydrophilic gel. The lipospheres were obtained by hot melt encapsulation method using as matrix ingredients a mixtures of esters of fatty acids with higher fatty alcohols, having low mel…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoOral mucosaAntifungalLipid microspheres
researchProduct

Transbuccal delivery of l-dopa methyl ester: ex vivo permeation studies

2012

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoL-DOPA methyl ester BUCCAL DELIVERY Parkinson Disease Porcine Buccal Mucosa Ex vivo permeation model
researchProduct